- Home
- APLT vs RMTI Comparison
APLT vs RMTI Comparison
Compare APLT & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- RMTI
- Stock Information
- Founded
- APLT 2016
- RMTI 1994
- Country
- APLT United States
- RMTI United States
- Employees
- APLT N/A
- RMTI N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- APLT Health Care
- RMTI Health Care
- Exchange
- APLT Nasdaq
- RMTI Nasdaq
- Market Cap
- APLT 63.6M
- RMTI 58.9M
- IPO Year
- APLT 2019
- RMTI 1998
- Fundamental
- Price
- APLT $0.41
- RMTI $1.61
- Analyst Decision
- APLT Buy
- RMTI Strong Buy
- Analyst Count
- APLT 6
- RMTI 2
- Target Price
- APLT $6.10
- RMTI $4.00
- AVG Volume (30 Days)
- APLT 771.9K
- RMTI 3.2M
- Earning Date
- APLT 11-06-2025
- RMTI 11-11-2025
- Dividend Yield
- APLT N/A
- RMTI N/A
- EPS Growth
- APLT N/A
- RMTI N/A
- EPS
- APLT N/A
- RMTI N/A
- Revenue
- APLT $121,000.00
- RMTI $87,966,000.00
- Revenue This Year
- APLT N/A
- RMTI N/A
- Revenue Next Year
- APLT $5,931.24
- RMTI $10.99
- P/E Ratio
- APLT N/A
- RMTI N/A
- Revenue Growth
- APLT N/A
- RMTI N/A
- 52 Week Low
- APLT $0.30
- RMTI $0.78
- 52 Week High
- APLT $10.62
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- APLT 38.50
- RMTI 56.96
- Support Level
- APLT $0.40
- RMTI $1.59
- Resistance Level
- APLT $0.46
- RMTI $1.85
- Average True Range (ATR)
- APLT 0.03
- RMTI 0.20
- MACD
- APLT -0.01
- RMTI -0.02
- Stochastic Oscillator
- APLT 7.74
- RMTI 30.99
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.